BioSpace News Archive

Researchers at the Earle A. Chiles Research Institute, a division of Providence Cancer Institute, are using TriAltus Bioscience, LLC protein purification technology to fast-track development of an ELISA test to monitor antibody responses to SARS-CoV-2 in patients that will receive a COVID-19 vaccine.

NeuroMetrix, Inc. (Nasdaq:NURO) announced today that it plans to issue its 2020 first quarter financial results before the opening of the market on Thursday, April 23, 2020

Cygnal Therapeutics today announced the publication of a new article in Cell, titled “Roadmap for the Emerging Field of Cancer Neuroscience.” Jonathan Hurov, Ph.D., who serves as Cygnal’s vice president of discovery biology and platforms, and multiple members of Cygnal’s Scientific Advisory Board are co-authors on the paper, among other scientists.

UltraCare Anesthesia Partners, a New Jersey based anesthesia management company consisting of both Certified Registered Nurse Anesthetists and Physician Anesthesiologists, is forming numerous response teams to help hospitals that are being hit hard by the COVID-19 virus.

In the past few weeks the State of Texas has issued orders that sharply limit the ability of the state’s physicians to take care of their patients, according to the Association of American Physicians and Surgeons, which has written a letter urging Gov. Greg Abbott to revoke these harmful rules.

CDC Foundation and Microsoft provide seed funds for unprecedented private sector coordination effort to address health and safety threats

Agios Pharmaceuticals, Inc. announced that the company will host a conference call and live webcast on Thursday, April 30, 2020 at 8:00 a.m. ET to report its first quarter 2020 financial results and other business highlights.

Non-branded versions of Humalog® Mix75/25™ KwikPen® and Humalog® Junior KwikPen® are now available for order by U.S. pharmacies – adding to the broad suite of affordability options offered by Eli Lilly and Company.

Smith to Deepen Strategic Leadership and Complement Commercial, Operational and Financial Expertise of the Board

Zimmer Biomet Holdings, Inc. announced its first quarter sales and earnings conference call will be broadcast over the Internet on Monday, May 11, 2020, at 8:30 a.m. Eastern Time.